High-Dose Cholera Vaccine Developed by UMSOM Scientists Shows Promise for Controlling Outbreaks
Description
Description of a promising cholera vaccine resulting from a study conducted in Mali by the University of Maryland, Baltimore, School of Medicine's Center for Vaccine Development (CVD). The new single-dose, live-attenuated oral vaccine is licensed and manufactured by PaxVax under the name of Vaxchora.Keyword
University of Maryland, Baltimore. Center for Vaccine Development (CVD)University of Maryland, Baltimore. School of Medicine
Cholera Vaccines